Is BCAX or BDTX more undervalued in 2026?

CirclFi compares Bicara Therapeutics Inc. (BCAX) and Black Diamond Therapeutics, Inc (BDTX) using 13 institutional-grade valuation models. BCAX has a Quality of Company score of 4.3/10 while BDTX scores 6.8/10.

Which is a better buy — BCAX or BDTX?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do BCAX and BDTX valuations compare?

BCAX at $21.75 and BDTX at $2.25 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

BCAX vs BDTX Valuation Comparison 2026 — Intrinsic Value Analysis

BCAX

Biotechnology

Bicara Therapeutics Inc.

Quality

4.3

out of 10

Value Trap

SAFE

Price

$21.75

Last close

Models

7/13

Active

BDTX

Biotechnology

Black Diamond Therapeutics, Inc

Quality

6.8

out of 10

Value Trap

LOW

Price

$2.25

Last close

Models

10/13

Active

Model-by-Model Comparison

Model	Type	BCAX Fair Value	BCAX Upside	BDTX Fair Value	BDTX Upside
Bayesian DCF	Intrinsic	$8.47	-61.1%	—	—
Earnings Power Value	Intrinsic	—	—	$4.63	+64.1%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$3.40	-84.4%	$1.92	-45.8%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for BCAX vs BDTX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

BCAX vs BDTX — Which Stock Is More Undervalued?

BDTX scores higher with a 6.8/10 quality rating vs BCAX's 4.3/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Bicara Therapeutics Inc. (BCAX) and Black Diamond Therapeutics, Inc (BDTX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

BCAX currently trades at $21.75 with a QOC of 4.3/10, while BDTX trades at $2.25 with a QOC of 6.8/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).